ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-0N17605
Home | Market Reports | Health| Pharmacy
Global Non carrier Added Lutetium 177 n c a Lu 177 Market Research Report 2024
BUY CHAPTERS

Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-0N17605
Report
October 2025
Pages:147
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
SHINE Technologies
NRG
Eckert & Ziegler
ITM
Isotopia
ANSTO
Monrol
China Tongfu Stock
Eckert & Ziegler

Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market

The global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Lutetium-177 is a radioactive isotope of lutetium, a rare earth metal, with a half-life of about 6.7 days. Lutetium-177 is a beta emitter, meaning that as it decays it releases beta radiation—high-energy electrons the unstable atom can no longer contain. Beta radiation is particularly useful for cancer treatment because of how effectively attenuated it is by biological soft tissues. By applying radioisotopes like Lu-177 to the right area, the beta radiation released can destroy tumors while causing minimal damage to the surrounding healthy tissue. Lu-177 also emits gamma radiation.
Lutetium-177 can be produced as carrier added (ca) and no carrier added (nca) from enriched 177Lu or 176Yb. The later requires separation of Lu from the Yb target following irradiation. Non-carrier added Lutetium-177 (n.c.a. Lu-177) is emerging as a radioisotope of choice for targeted radionuclide therapy.
From a downstream perspective, Targeted Molecular Radiotherapy accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Non-carrier Added Lutetium-177 (n.c.a. Lu-177) leading manufacturers including SHINE Technologies, NRG, Eckert & Ziegler, ITM, Isotopia Ltd, ANSTO, Monrol, China Tongfu Stock, etc., dominate supply; the top five capture approximately % of global revenue, with SHINE Technologies leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Specification and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Report

Report Metric Details
Report Name Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market
Segment by Specification
  • 50 GBq/mL
  • 200 GBq/mL
  • Others
Segment by Application
  • Targeted Molecular Radiotherapy
  • Medical Imaging
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company SHINE Technologies, NRG, Eckert & Ziegler, ITM, Isotopia Ltd, ANSTO, Monrol, China Tongfu Stock
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Non-carrier Added Lutetium-177 (n.c.a. Lu-177) study scope, segments the market by Specification and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Specification, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Specification, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Specification, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Specification, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Specification, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market report?

Ans: The main players in the Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market are SHINE Technologies, NRG, Eckert & Ziegler, ITM, Isotopia Ltd, ANSTO, Monrol, China Tongfu Stock

What are the Application segmentation covered in the Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market report?

Ans: The Applications covered in the Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market report are Targeted Molecular Radiotherapy, Medical Imaging

1 Study Coverage
1.1 Introduction to Non-carrier Added Lutetium-177 (n.c.a. Lu-177): Definition, Properties, and Key Attributes
1.2 Market Segmentation by Specification
1.2.1 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size by Specification, 2020 VS 2024 VS 2031
1.2.2 50 GBq/mL
1.2.3 200 GBq/mL
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Targeted Molecular Radiotherapy
1.3.3 Medical Imaging
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Estimates and Forecasts 2020-2031
2.2 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Estimates and Forecasts 2020-2031
2.4 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 50 GBq/mL Market Size by Manufacturers
3.5.2 200 GBq/mL Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Performance by Specification
4.1.1 Global Historical and Forecasted Sales by Specification (2020-2031)
4.1.2 Global Sales Market Share by Specification (2020-2031)
4.2 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Trends by Specification
4.2.1 Global Historical and Forecasted Revenue by Specification (2020-2031)
4.2.2 Global Revenue Market Share by Specification (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Specification (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales and Revenue by Specification (2020-2031)
6.4 North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales and Revenue by Specification (2020-2031)
7.4 Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales and Revenue by Specification (2020-2031)
8.4 Asia-Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales and Revenue by Specification (2020-2031)
9.4 Central and South America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales and Revenue by Specification (2020-2031)
10.4 Middle East and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 SHINE Technologies
11.1.1 SHINE Technologies Corporation Information
11.1.2 SHINE Technologies Business Overview
11.1.3 SHINE Technologies Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product Models, Descriptions and Specifications
11.1.4 SHINE Technologies Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 SHINE Technologies Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Product in 2024
11.1.6 SHINE Technologies Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Application in 2024
11.1.7 SHINE Technologies Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Geographic Area in 2024
11.1.8 SHINE Technologies Non-carrier Added Lutetium-177 (n.c.a. Lu-177) SWOT Analysis
11.1.9 SHINE Technologies Recent Developments
11.2 NRG
11.2.1 NRG Corporation Information
11.2.2 NRG Business Overview
11.2.3 NRG Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product Models, Descriptions and Specifications
11.2.4 NRG Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 NRG Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Product in 2024
11.2.6 NRG Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Application in 2024
11.2.7 NRG Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Geographic Area in 2024
11.2.8 NRG Non-carrier Added Lutetium-177 (n.c.a. Lu-177) SWOT Analysis
11.2.9 NRG Recent Developments
11.3 Eckert & Ziegler
11.3.1 Eckert & Ziegler Corporation Information
11.3.2 Eckert & Ziegler Business Overview
11.3.3 Eckert & Ziegler Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product Models, Descriptions and Specifications
11.3.4 Eckert & Ziegler Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Eckert & Ziegler Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Product in 2024
11.3.6 Eckert & Ziegler Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Application in 2024
11.3.7 Eckert & Ziegler Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Geographic Area in 2024
11.3.8 Eckert & Ziegler Non-carrier Added Lutetium-177 (n.c.a. Lu-177) SWOT Analysis
11.3.9 Eckert & Ziegler Recent Developments
11.4 ITM
11.4.1 ITM Corporation Information
11.4.2 ITM Business Overview
11.4.3 ITM Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product Models, Descriptions and Specifications
11.4.4 ITM Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 ITM Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Product in 2024
11.4.6 ITM Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Application in 2024
11.4.7 ITM Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Geographic Area in 2024
11.4.8 ITM Non-carrier Added Lutetium-177 (n.c.a. Lu-177) SWOT Analysis
11.4.9 ITM Recent Developments
11.5 Isotopia Ltd
11.5.1 Isotopia Ltd Corporation Information
11.5.2 Isotopia Ltd Business Overview
11.5.3 Isotopia Ltd Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product Models, Descriptions and Specifications
11.5.4 Isotopia Ltd Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Isotopia Ltd Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Product in 2024
11.5.6 Isotopia Ltd Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Application in 2024
11.5.7 Isotopia Ltd Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Geographic Area in 2024
11.5.8 Isotopia Ltd Non-carrier Added Lutetium-177 (n.c.a. Lu-177) SWOT Analysis
11.5.9 Isotopia Ltd Recent Developments
11.6 ANSTO
11.6.1 ANSTO Corporation Information
11.6.2 ANSTO Business Overview
11.6.3 ANSTO Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product Models, Descriptions and Specifications
11.6.4 ANSTO Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 ANSTO Recent Developments
11.7 Monrol
11.7.1 Monrol Corporation Information
11.7.2 Monrol Business Overview
11.7.3 Monrol Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product Models, Descriptions and Specifications
11.7.4 Monrol Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Monrol Recent Developments
11.8 China Tongfu Stock
11.8.1 China Tongfu Stock Corporation Information
11.8.2 China Tongfu Stock Business Overview
11.8.3 China Tongfu Stock Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product Models, Descriptions and Specifications
11.8.4 China Tongfu Stock Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 China Tongfu Stock Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Industry Chain
12.2 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
SHINE Technologies
NRG
Eckert & Ziegler
ITM
Isotopia
ANSTO
Monrol
China Tongfu Stock
Eckert & Ziegler
List of Tables
 Table 1. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size Growth Rate by Specification, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Dose)
 Table 7. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Region (2020-2025) & (Dose)
 Table 8. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Region (2026-2031) & (Dose)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Manufacturers (2020-2025) & (Dose)
 Table 11. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Share by Manufacturers (2020-2025)
 Table 12. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-carrier Added Lutetium-177 (n.c.a. Lu-177) as of 2024)
 Table 16. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Dose)
 Table 18. Key Manufacturers Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Manufacturing Base and Headquarters
 Table 19. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Specification (2020-2025) & (Dose)
 Table 23. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Specification (2026-2031) & (Dose)
 Table 24. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Specification (2020-2025) & (US$ Million)
 Table 25. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Specification (2026-2031) & (US$ Million)
 Table 26. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) ASP by Specification (2020-2031) & (US$/Dose)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Application (2020-2025) & (Dose)
 Table 29. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales by Application (2026-2031) & (Dose)
 Table 30. Non-carrier Added Lutetium-177 (n.c.a. Lu-177) High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) ASP by Application (2020-2031) & (US$/Dose)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Growth Accelerators and Market Barriers
 Table 37. North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales (Dose) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Growth Accelerators and Market Barriers
 Table 40. Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales (Dose) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales (Dose) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Investment Opportunities and Key Challenges
 Table 47. Central and South America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. SHINE Technologies Corporation Information
 Table 51. SHINE Technologies Description and Major Businesses
 Table 52. SHINE Technologies Product Models, Descriptions and Specifications
 Table 53. SHINE Technologies Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 54. SHINE Technologies Sales Value Proportion by Product in 2024
 Table 55. SHINE Technologies Sales Value Proportion by Application in 2024
 Table 56. SHINE Technologies Sales Value Proportion by Geographic Area in 2024
 Table 57. SHINE Technologies Non-carrier Added Lutetium-177 (n.c.a. Lu-177) SWOT Analysis
 Table 58. SHINE Technologies Recent Developments
 Table 59. NRG Corporation Information
 Table 60. NRG Description and Major Businesses
 Table 61. NRG Product Models, Descriptions and Specifications
 Table 62. NRG Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 63. NRG Sales Value Proportion by Product in 2024
 Table 64. NRG Sales Value Proportion by Application in 2024
 Table 65. NRG Sales Value Proportion by Geographic Area in 2024
 Table 66. NRG Non-carrier Added Lutetium-177 (n.c.a. Lu-177) SWOT Analysis
 Table 67. NRG Recent Developments
 Table 68. Eckert & Ziegler Corporation Information
 Table 69. Eckert & Ziegler Description and Major Businesses
 Table 70. Eckert & Ziegler Product Models, Descriptions and Specifications
 Table 71. Eckert & Ziegler Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 72. Eckert & Ziegler Sales Value Proportion by Product in 2024
 Table 73. Eckert & Ziegler Sales Value Proportion by Application in 2024
 Table 74. Eckert & Ziegler Sales Value Proportion by Geographic Area in 2024
 Table 75. Eckert & Ziegler Non-carrier Added Lutetium-177 (n.c.a. Lu-177) SWOT Analysis
 Table 76. Eckert & Ziegler Recent Developments
 Table 77. ITM Corporation Information
 Table 78. ITM Description and Major Businesses
 Table 79. ITM Product Models, Descriptions and Specifications
 Table 80. ITM Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 81. ITM Sales Value Proportion by Product in 2024
 Table 82. ITM Sales Value Proportion by Application in 2024
 Table 83. ITM Sales Value Proportion by Geographic Area in 2024
 Table 84. ITM Non-carrier Added Lutetium-177 (n.c.a. Lu-177) SWOT Analysis
 Table 85. ITM Recent Developments
 Table 86. Isotopia Ltd Corporation Information
 Table 87. Isotopia Ltd Description and Major Businesses
 Table 88. Isotopia Ltd Product Models, Descriptions and Specifications
 Table 89. Isotopia Ltd Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 90. Isotopia Ltd Sales Value Proportion by Product in 2024
 Table 91. Isotopia Ltd Sales Value Proportion by Application in 2024
 Table 92. Isotopia Ltd Sales Value Proportion by Geographic Area in 2024
 Table 93. Isotopia Ltd Non-carrier Added Lutetium-177 (n.c.a. Lu-177) SWOT Analysis
 Table 94. Isotopia Ltd Recent Developments
 Table 95. ANSTO Corporation Information
 Table 96. ANSTO Description and Major Businesses
 Table 97. ANSTO Product Models, Descriptions and Specifications
 Table 98. ANSTO Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 99. ANSTO Recent Developments
 Table 100. Monrol Corporation Information
 Table 101. Monrol Description and Major Businesses
 Table 102. Monrol Product Models, Descriptions and Specifications
 Table 103. Monrol Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 104. Monrol Recent Developments
 Table 105. China Tongfu Stock Corporation Information
 Table 106. China Tongfu Stock Description and Major Businesses
 Table 107. China Tongfu Stock Product Models, Descriptions and Specifications
 Table 108. China Tongfu Stock Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 109. China Tongfu Stock Recent Developments
 Table 110. Key Raw Materials Distribution
 Table 111. Raw Materials Key Suppliers
 Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 113. Milestones in Production Technology Evolution
 Table 114. Distributors List
 Table 115. Market Trends and Market Evolution
 Table 116. Market Drivers and Opportunities
 Table 117. Market Challenges, Risks, and Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources


List of Figures
 Figure 1. Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Product Picture
 Figure 2. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size Growth Rate by Specification, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. 50 GBq/mL Product Picture
 Figure 4. 200 GBq/mL Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Targeted Molecular Radiotherapy
 Figure 8. Medical Imaging
 Figure 9. Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Report Years Considered
 Figure 10. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Market Share by Region (2020-2031)
 Figure 14. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales (2020-2031) & (Dose)
 Figure 15. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales (CAGR) by Region (2020-2031) (Dose)
 Figure 16. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Volume Market Share in 2024
 Figure 18. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. 50 GBq/mL Revenue Market Share by Manufacturer in 2024
 Figure 21. 200 GBq/mL Revenue Market Share by Manufacturer in 2024
 Figure 22. Others Revenue Market Share by Manufacturer in 2024
 Figure 23. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Market Share by Specification (2020-2031)
 Figure 24. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Market Share by Specification (2020-2031)
 Figure 25. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Market Share by Application (2020-2031)
 Figure 26. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue Market Share by Application (2020-2031)
 Figure 27. North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales YoY (2020-2031) & (Dose)
 Figure 28. North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. North America Top 5 Manufacturers Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Revenue (US$ Million) in 2024
 Figure 30. North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Volume (Dose) by Specification (2020- 2031)
 Figure 31. North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Revenue (US$ Million) by Specification (2020 - 2031)
 Figure 32. North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Volume (Dose) by Application (2020-2031)
 Figure 33. North America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 34. US Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (2020-2031) & (US$ Million)
 Figure 35. Canada Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (2020-2031) & (US$ Million)
 Figure 36. Mexico Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (2020-2031) & (US$ Million)
 Figure 37. Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales YoY (2020-2031) & (Dose)
 Figure 38. Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Europe Top 5 Manufacturers Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Revenue (US$ Million) in 2024
 Figure 40. Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Volume (Dose) by Specification (2020-2031)
 Figure 41. Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Revenue (US$ Million) by Specification (2020-2031)
 Figure 42. Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Volume (Dose) by Application (2020-2031)
 Figure 43. Europe Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Germany Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (2020-2031) & (US$ Million)
 Figure 45. France Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (2020-2031) & (US$ Million)
 Figure 46. U.K. Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (2020-2031) & (US$ Million)
 Figure 47. Italy Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (2020-2031) & (US$ Million)
 Figure 48. Russia Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales YoY (2020-2031) & (Dose)
 Figure 50. Asia-Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Top 8 Manufacturers Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Revenue (US$ Million) in 2024
 Figure 52. Asia-Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Volume (Dose) by Specification (2020- 2031)
 Figure 53. Asia-Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Revenue (US$ Million) by Specification (2020- 2031)
 Figure 54. Asia-Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Volume (Dose) by Application (2020-2031)
 Figure 55. Asia-Pacific Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Indonesia Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (2020-2031) & (US$ Million)
 Figure 57. Japan Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (2020-2031) & (US$ Million)
 Figure 58. South Korea Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (2020-2031) & (US$ Million)
 Figure 59. China Taiwan Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (2020-2031) & (US$ Million)
 Figure 60. India Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (2020-2031) & (US$ Million)
 Figure 61. Central and South America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales YoY (2020-2031) & (Dose)
 Figure 62. Central and South America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Central and South America Top 5 Manufacturers Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Revenue (US$ Million) in 2024
 Figure 64. Central and South America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Volume (Dose) by Specification (2021-2031)
 Figure 65. Central and South America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Revenue (US$ Million) by Specification (2020-2031)
 Figure 66. Central and South America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Volume (Dose) by Application (2020-2031)
 Figure 67. Central and South America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 68. Brazil Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (2020-2025) & (US$ Million)
 Figure 69. Argentina Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (2020-2025) & (US$ Million)
 Figure 70. Middle East, and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales YoY (2020-2031) & (Dose)
 Figure 71. Middle East and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Middle East and Africa Top 5 Manufacturers Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Revenue (US$ Million) in 2024
 Figure 73. Middle East and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Volume (Dose) by Specification (2021-2031)
 Figure 74. South America Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Revenue (US$ Million) by Specification (2020-2031)
 Figure 75. Middle East and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Volume (Dose) by Application (2020-2031)
 Figure 76. Middle East and Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. GCC Countries Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (2020-2025) & (US$ Million)
 Figure 78. Turkey Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (2020-2025) & (US$ Million)
 Figure 79. Egypt Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (2020-2025) & (US$ Million)
 Figure 80. South Africa Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Revenue (2020-2025) & (US$ Million)
 Figure 81. Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Industry Chain Mapping
 Figure 82. Regional Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Manufacturing Base Distribution (%)
 Figure 83. Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Production Market Share by Region (2020-2031)
 Figure 84. Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Production Process
 Figure 85. Regional Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Production Cost Structure
 Figure 86. Channels of Distribution (Direct Vs Distribution)
 Figure 87. Bottom-up and Top-down Approaches for This Report
 Figure 88. Data Triangulation
 Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Lutetium 177 Lu 177 Market Research Report 2025
High Purity Lutetium Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lutetium Resources Market Research Report 2024
Global Lutetium Sputtering Target Market Research Report 2024
Global Astatine 211 Market Research Report 2025
Global Molybdenum 99 Mo 99 Market Research Report 2025
Global Lutetium Yttrium Silicate Scintillator Crystal Market Research Report 2024
Global Lutetium 176 Market Research Report 2024
Global Europium Chelate Microsphere Market Research Report 2024
Lutetium Oxide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lutetium Lu Evaporation Materials Market Research Report 2024
Global Lutetium Foil Market Research Report 2024
Global Europium Nanoparticle in Biological Sector Market Research Report 2025
Global Lutetium Metal Market Research Report 2025
Global Lutetium III Nitrate Market Research Report 2024
Global Iridium 192 Market Research Report 2025
Global Gadolinium 148 Market Research Report 2025
Global Lutetium Oxide Sputtering Target Market Research Report 2024
Global Europium Nanoparticle for Rapid Diagnosis Market Research Report 2025
Global Lutetium Nitride Market Research Report 2024

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions